Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

The Cult of Tesla: Are Investors Buying Cars or Castles in the Air?

Musk may become the world’s first trillionaire. But you won’t get a taste of it investing in his car company.

CRWD Stock Alert: CrowdStrike Joins the S&P 500 Today

CRWD stock is up over 300% since its 2019 IPO. Being added to the index nearly always boosts a stock price.

Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success

The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare.

Can Rivian Stock Cross the Electric Vehicle Death Valley?

The odds against Rivian stock are long, but if it can execute and the market recovers you will look like a genius.

Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost

How much Sarepta can hope to earn from Elevidys is unclear due to its cost, $3 million, and that it's not a cure. Yet SRPT stock is surging.